Quantcast

Latest autoimmune diseases Stories

Multiple Sclerosis Patients Could Benefit From Increased Vitamin D Intake
2014-01-21 05:04:08

Karen Feldscher, Harvard School of Public Health For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health (HSPH) investigators in collaboration with Bayer HealthCare. The findings suggest that patients in the early stages of MS could stave off disease symptoms by increasing their vitamin D intake. "Because low vitamin D...

2014-01-17 23:20:36

Founder Sharon Kleyne Reports the Latest Discoveries on Relationship Between Dry Eye and Swollen Eyes (PRWEB) January 17, 2014 “Swollen eyes,” according to Bio Logic Aqua Research Founder Sharon Kleyne, is one of the most common symptoms of winter dry eye. Kleyne notes that “swollen eyes” can refer either to “blepharitis,” which is inflammation of the eyelids, “conjunctivitis, which is inflammation of the ocular conjunctiva, the layer of living tissue over the eyes that...

2014-01-17 16:23:40

WASHINGTON, Jan. 17, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America applauds Congress for enacting the Consolidated Appropriations Act of 2014, H.R. 3547, which provides funding for vital lupus research and education programs. While the legislation provides good news for the fight against lupus, the omnibus bill only partially restores National Institutes of Health (NIH) funds that were previously cut from federal budgets through the automatic spending reductions known as...

2014-01-16 16:24:09

AUSTIN, Texas, Jan. 16, 2014 /PRNewswire/ -- XBiotech announced today that it has launched a Phase II study to treat a rare but debilitating disorder, Pyoderma Gangrenosum (PG). This study is based on efficacy seen with anti-IL-1 therapeutic antibody in previous dermatological clinical studies such as psoriasis and acne. PG is expected to be considered an "orphan indication" by the FDA, facilitating expedited clinical development to market. Dr. Armand Cognetta, lead clinical...

2014-01-15 08:29:25

Collaboration Brings Unique Expertise Together THOUSAND OAKS, Calif., Jan. 15, 2014 /PRNewswire/ -- Massachusetts General Hospital (MGH), the Broad Institute, and Amgen (NASDAQ:AMGN) announced today that they have launched a strategic collaboration to jointly discover and validate new therapeutic targets and develop novel therapies for inflammatory bowel disease (IBD), a chronic disorder that affects millions worldwide. The MGH-Broad-Amgen collaboration brings together...

2014-01-14 16:25:08

Brings Total to $6.6 Million to Educate Healthcare Professionals on Front-Lines of Care NEW YORK, Jan. 14, 2014 /PRNewswire/ -- The 2014 Omnibus Appropriations Bill released by the U.S. Congress last night provides $2 million to further the Lupus Initiative, the lupus provider education program conceived by the Lupus Research Institute (LRI) in collaboration with the federal government. Expected to pass this week, the appropriation will bring total support to $6.6 million for the...

2014-01-13 08:26:42

PETACH TIKVA, Israel, Jan. 13, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it will present new data based on a further analysis of results from its Phase IIb study of CF101 for the treatment of Rheumatoid Arthritis and interim data from its Phase II/III study of CF101 for the treatment of Psoriasis at the...

FDA Approves Novel AstraZeneca, Bristol-Meyers Squibb Diabetes Drug
2014-01-10 11:37:58

Ranjini Raghunath for redOrbit.com - Your Universe Online The FDA has approved the use of a new Type 2 diabetes drug called Farxiga, developed by pharmaceutical companies Bristol-Meyers Squibb and AstraZeneca. Type 2 diabetes affects 24 million people in the US and nearly 350 million people worldwide. Conventional diabetes drugs work by reducing the amount of sugar the body absorbs from food or by boosting the production of insulin which disposes of excess sugar. Farxiga, however,...

2014-01-09 23:26:38

Dr. James Wells, of South Charlotte Dentistry, is excited about sharing information about Rheumatoid Arthritis as it relates to dental health with his patients and the community. (PRWEB) January 09, 2014 In recent years, we’ve learned more and more about the link between a healthy mouth and a healthy body. But now research is pointing to specific connections of certain types of bacteria and diseases, in particular Rheumatoid Arthritis (RA). Dr. James Wells, of South Charlotte...

2014-01-09 08:28:46

Renewed commitment over two years helps support education for students with type 1 diabetes INDIANAPOLIS and ROLLING MEADOWS, Ill., Jan. 9, 2014 /PRNewswire/ -- Today Lilly Diabetes announced it will renew its commitment to the Diabetes Scholars Foundation (Foundation) scholarship fund for another two years. The commitment includes a $200,000 donation ($100,000 for each calendar year) that will support the Foundation's mission: to empower young people with type 1 diabetes to live...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related